U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Bicarbonaturia

MedGen UID:
326596
Concept ID:
C1839865
Finding
Synonyms: Increased urine bicarbonate concentration; Increased urine HCO3 concentration
 
HPO: HP:0003646

Definition

Abnormally increased concentration of hydrogencarbonate in the urine. [from HPO]

Conditions with this feature

Hereditary fructosuria
MedGen UID:
42105
Concept ID:
C0016751
Disease or Syndrome
Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalaninemia) and clinical findings (nausea, vomiting, and abdominal distress; chronic growth restriction / failure to thrive). While untreated HFI typically first manifested when fructose- and sucrose-containing foods were introduced in the course of weaning young infants from breast milk, it is now presenting earlier, due to the addition of fructose-containing nutrients in infant formulas. If the infant ingests large quantities of fructose, the infant may acutely develop lethargy, seizures, and/or progressive coma. Untreated HFI may result in renal and hepatic failure. If identified and treated before permanent organ injury occurs, individuals with HFI can experience a normal quality of life and life expectancy.
Lowe syndrome
MedGen UID:
18145
Concept ID:
C0028860
Disease or Syndrome
Lowe syndrome (oculocerebrorenal syndrome) is characterized by involvement of the eyes, central nervous system, and kidneys. Dense congenital cataracts are found in all affected boys and infantile glaucoma in approximately 50%. All boys have impaired vision; corrected acuity is rarely better than 20/100. Generalized hypotonia is noted at birth and is of central (brain) origin. Deep tendon reflexes are usually absent. Hypotonia may slowly improve with age, but normal motor tone and strength are never achieved. Motor milestones are delayed. Almost all affected males have some degree of intellectual disability; 10%-25% function in the low-normal or borderline range, approximately 25% in the mild-to-moderate range, and 50%-65% in the severe-to-profound range of intellectual disability. Affected males have varying degrees of proximal renal tubular dysfunction of the Fanconi type, including low molecular-weight (LMW) proteinuria, aminoaciduria, bicarbonate wasting and renal tubular acidosis, phosphaturia with hypophosphatemia and renal rickets, hypercalciuria, sodium and potassium wasting, and polyuria. The features of symptomatic Fanconi syndrome do not usually become manifest until after the first few months of life, except for LMW proteinuria. Glomerulosclerosis associated with chronic tubular injury usually results in slowly progressive chronic renal failure and end-stage renal disease between the second and fourth decades of life.

Professional guidelines

PubMed

Leaf DE, Goldfarb DS
J Appl Physiol (1985) 2007 Apr;102(4):1313-22. Epub 2006 Oct 5 doi: 10.1152/japplphysiol.01572.2005. PMID: 17023566

Recent clinical studies

Etiology

Lai S, Mariotti A, Lai C, Testorio M, Carta M, Innico G, Frassetti N, Mangiulli M, D'Angelo A, Russo GE
Curr Vasc Pharmacol 2015;13(5):670-5. doi: 10.2174/1570161112666141120131850. PMID: 25412689
Neiberger RE, George JC, Perkins LA, Theriaque DW, Hutson AD, Stacpoole PW
Am J Kidney Dis 2002 Jan;39(1):12-23. doi: 10.1053/ajkd.2002.29872. PMID: 11774096
Kamel KS, Harvey E, Douek K, Parmar MS, Halperin ML
Am J Nephrol 1998;18(1):42-9. doi: 10.1159/000013303. PMID: 9481438
Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY
J Urol 1993 Aug;150(2 Pt 1):310-2. doi: 10.1016/s0022-5347(17)35468-x. PMID: 8326549
Lameire N, Matthys E
Am J Kidney Dis 1986 Sep;8(3):151-8. doi: 10.1016/s0272-6386(86)80018-x. PMID: 3019127

Diagnosis

Deepthi B, Krishnamurthy S, Karunakar P, Barathidasan G, Rajavelu TN
CEN Case Rep 2022 Aug;11(3):347-350. Epub 2022 Jan 20 doi: 10.1007/s13730-021-00675-x. PMID: 35048353Free PMC Article
Lai S, Mariotti A, Lai C, Testorio M, Carta M, Innico G, Frassetti N, Mangiulli M, D'Angelo A, Russo GE
Curr Vasc Pharmacol 2015;13(5):670-5. doi: 10.2174/1570161112666141120131850. PMID: 25412689
Zhang J, Fuster DG, Cameron MA, Quiñones H, Griffith C, Xie XS, Moe OW
Am J Physiol Renal Physiol 2014 Nov 1;307(9):F1063-71. Epub 2014 Aug 27 doi: 10.1152/ajprenal.00408.2014. PMID: 25164082Free PMC Article
Maia ML, do Val ML, Genzani CP, Fernandes FA, de Andrade MC, Carvalhaes JT
J Bras Nefrol 2010 Apr-Jun;32(2):216-22. PMID: 21103682
Kamel KS, Harvey E, Douek K, Parmar MS, Halperin ML
Am J Nephrol 1998;18(1):42-9. doi: 10.1159/000013303. PMID: 9481438

Therapy

Deepthi B, Krishnamurthy S, Karunakar P, Barathidasan G, Rajavelu TN
CEN Case Rep 2022 Aug;11(3):347-350. Epub 2022 Jan 20 doi: 10.1007/s13730-021-00675-x. PMID: 35048353Free PMC Article
Lai S, Mariotti A, Lai C, Testorio M, Carta M, Innico G, Frassetti N, Mangiulli M, D'Angelo A, Russo GE
Curr Vasc Pharmacol 2015;13(5):670-5. doi: 10.2174/1570161112666141120131850. PMID: 25412689
Leaf DE, Goldfarb DS
J Appl Physiol (1985) 2007 Apr;102(4):1313-22. Epub 2006 Oct 5 doi: 10.1152/japplphysiol.01572.2005. PMID: 17023566
Kamel KS, Harvey E, Douek K, Parmar MS, Halperin ML
Am J Nephrol 1998;18(1):42-9. doi: 10.1159/000013303. PMID: 9481438
Flamenbaum W, Friedman R
Pharmacotherapy 1982 Jul-Aug;2(4):213-22. doi: 10.1002/j.1875-9114.1982.tb03188.x. PMID: 6763204

Prognosis

Limsuwat C, Prabhakar SS
Am J Med Sci 2012 Sep;344(3):245-7. doi: 10.1097/MAJ.0b013e318254bd71. PMID: 22929613
Flamenbaum W, Friedman R
Pharmacotherapy 1982 Jul-Aug;2(4):213-22. doi: 10.1002/j.1875-9114.1982.tb03188.x. PMID: 6763204

Clinical prediction guides

Limsuwat C, Prabhakar SS
Am J Med Sci 2012 Sep;344(3):245-7. doi: 10.1097/MAJ.0b013e318254bd71. PMID: 22929613
Kamar N, Huart A, Tack I, Alric L, Izopet J, Rostaing L
Clin Nephrol 2009 Jan;71(1):36-42. doi: 10.5414/cnp71036. PMID: 19203548
Anderson RJ, Gabow PA, Gross PA
Miner Electrolyte Metab 1984;10(2):92-7. PMID: 6700567
Flamenbaum W, Friedman R
Pharmacotherapy 1982 Jul-Aug;2(4):213-22. doi: 10.1002/j.1875-9114.1982.tb03188.x. PMID: 6763204
Fox IH, Halperin ML, Goldstein MB, Marliss ER
Metabolism 1976 May;25(5):551-9. doi: 10.1016/0026-0495(76)90009-3. PMID: 1263845

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...